1984•PubMedRequires access

Droperidol vs. haloperidol in the initial management of acutely agitated patients.

Michael Resnick, Brent T. Burton

Abstract

In a double-blind clinical study, 27 acutely agitated patients were treated with an intramuscular injection of 5 mg of droperidol or 5 mg of haloperidol from identical appearing vials. At 30 minutes following treatment, 81% of the patients treated with haloperidol but only 36% treated with droperidol required a second injection (p less than .05). Thus, droperidol, a safe butyrophenone neuroleptic, appears to be a drug of choice for rapid and reliable control of acute agitation.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 91 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Droperidol, Butyrophenone, Haloperidol, Anesthesia, Medicine, Intramuscular injection, Pharmacology, Internal medicine